steatotic liver disease

News

GSK buys liver drug from Boston Pharmaceuticals

GSK to buy liver disease drug for up to $2 billion

GSK will buy efimosfermin, a liver disease drug in late-stage trials, for up to $2 billion from U.S. biotechnology firm Boston Pharmaceuticals, the British drugmaker said on Wednesday. Efimosfermin, a monthly subcutaneous injection,

· 1d · on MSN

Zacks Investment Research on MSN · 16h

GSK Inks $2B Deal With Boston Pharmaceuticals to Buy Liver Disease Drug

· 1d

GSK buys liver disease drug for up to $2 bn

European Medical Journal13h

Steatotic Liver Disease and Frailty in Older Adults

Discover a study that offers new insight into the link between frailty and steatotic liver disease in older adults.

12don MSN

Semaglutide found to have shocking benefit for liver disease patients in new study

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

Science Daily16h

Research shows how hormone can reverse fatty liver disease in mice

A pioneering research study details how the hormone FGF21 (fibroblast growth factor 21) can reverse the effects of fatty liver disease in mice. The hormone works primarily by signaling the brain to ...

Technology Networks1d

FGF21 Hormone Can Reverse Fatty Liver Disease

The researchers found that FGF21 activates a signaling pathway in the brain that triggers changes in nerve activity directed ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results